Impact of Clinical Pathways on Lung Cancer Management

Drug Development in the 21st Century

NICE: It Takes Two to Tango

What’s New from the 2016 ESMO Clinical Guidelines

Update to the “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors”

Global Nursing Impact of Immunotherapy in Lung Cancer

National Comprehensive Cancer Network NSCLC Guideline Updates for 2016: Non-Small Cell Lung Cancer

Nurses Treating Lung Cancer, IASLC and Beyond

Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030

COVID-19 and Lung Cancer

The Art and Science of Patient–Doctor Communication

In Brief for February 9, 2022